Marksans Pharma Launches Omeprazole Tablets

  Published 11 months ago

Marksans Pharma introduced bioequivalent Omeprazole 20 mg tablets, matching Prilosec OTC, for heartburn and acid-related disorder treatment.

  • Omeprazole is a proton pump inhibitor effective in treating GERD, dyspepsia, and heartburn by reducing excess stomach acid.
  • Product matches reference drug Prilosec OTC 20 mg, marketed by AstraZeneca under NDA 021229, ensuring equivalent efficacy and safety.
  • Marksans operates globally with USFDA, UKMHRA, and TGA-approved facilities, offering a diversified portfolio across multiple therapeutic segments.

You might like these

Lemon Tree Launches Third Jaipur Hotel

Aditya Birla Fashion Shares Plunge 10% on Flipkart Stake Sale

Wipro Expands in Saudi Arabia with New Office and Tech Training Center

AROK UAV: India's High Altitude Surveillance Powerhouse

PGEL, PAX Begin Local POS Production

RBI Simplifies KYC Norms 2025

Nxtra, AMPIN Expand Green Energy Deal

News that matters the most ⚡